Normalisation of [89Zr]Zr-trastuzumab uptake and tumour-to-blood contrast ratios to corresponding values obtained with [111In]In-IgG resulted in metrics strongly correlated with empirically determined HER2 expression levels. The gene discussed is ERBB2; the disease is neoplasm.